According to the KDIGO (Kidney Disease Improving Global Outcomes) 2017 clinical practice guideline update for the diagnosis, prevention, and treatment of chronic kidney disease–mineral and bone disorder, serum level of calcium, phosphate, PTH and alkaline phosphatase were recommended monitoring since CKD stage 3a. Here, PTH is linked to bone disorder.